Outsourced Pharma Webinars

  1. The Crucial Role Of Apheresis In Cellular Therapies 1/8/2025

    Gain valuable insights into the critical role of apheresis in sourcing high-quality cellular material for therapies.

  2. Exploring New And Improved Analytical Methods For Traditional And Unique Modalities 1/2/2025

    Here, we review several challenges in biologics analysis and take a closer look at the advanced tools and methods being utilized to improve biophysical analysis reliability and efficiency.

  3. BioPhorum Raw Materials Risk Assessments 12/19/2024

    Torsten Schaderdorf provides an in-depth exploration of current regulations related to Raw Materials Risk Assessment, highlighting the risk criteria and raw material scope outlined in the BioPhorum guidelines.

  4. Assemblies Are Not Particulate Free, Strategies For Risk Mitigation 12/19/2024

    As single-use technologies gain prominence in critical applications, the scrutiny around particulate contamination intensifies due to its potential impact on drug product quality, safety, and patient outcomes.

  5. Transforming The Biopharma Supply Chain, eData Solutions For Agility And Manufacturing Efficiency 12/19/2024

    Explore the role of eData in automating processes, enabling predictive analytics, improving supply chain resilience, and adopting standardized digital platforms in biopharma manufacturing.

  6. Managing Nitrite Impurities: Supplier-Manufacturer View 12/19/2024

    Examine nitrites in excipients, nitrosamine risks, regulatory considerations, analytical controls, and a case study on mitigating risks in pharmaceutical manufacturing and storage.

  7. How Standardized Extractables Data Support E&L Risk Assessment 12/19/2024

    Explore E&L evaluations, USP <665>, supplier-provided extractables data, and collaborative strategies to mitigate risks in Single-Use Systems for biopharmaceutical manufacturing processes.

  8. Evaluating USP 665 For Extractables Testing And Reducing Animal Testing For Biological Reactivity 12/19/2024

    Explore evolving compendial methods, USP <665>, and transitioning to cell-based assays for extractables, leachables, and biological reactivity in single-use pharmaceutical manufacturing.

  9. Challenges Using Multiple Single-Use Systems Functionality Versus Extractables And Leachables 12/19/2024

    Explore a risk assessment of extractables, evaluating single-use components, and addressing complexities in manufacturing processes, with a case study highlighting compatibility and patient safety concerns.

  10. Demystifying Large Scale Continuous Chromatography For Small Molecules 12/18/2024

    Learn the fundamentals of developing a continuous chromatography process with Simulated Moving Bed (SMB) technology for small molecules, from gram-scale to multi-ton commercial production.